UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

Frontiers in immunology, 2022-01, Vol.12, p.798602

2022

Link zum Volltext

Verfügbarkeit prüfen

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

European journal of internal medicine, 2017-07, Vol.42, p.81-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients

Viruses, 2022-04, Vol.14 (4), p.787

2022

Link zum Volltext

Verfügbarkeit prüfen

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases

PloS one, 2015-08, Vol.10 (8), p.e0135486-e0135486

2015

Link zum Volltext

Verfügbarkeit prüfen

Decreased serum DNase1-activity in patients with autoimmune liver diseases

Autoimmunity (Chur, Switzerland), 2017-03, Vol.50 (2), p.125-132

2017

Link zum Volltext

Verfügbarkeit prüfen

NAFLD and autoimmune hepatitis: Do not judge a book by its cover

European journal of internal medicine, 2020-05, Vol.75, p.1-9

2020

Link zum Volltext

Verfügbarkeit prüfen

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

Journal of viral hepatitis, 2020-02, Vol.27 (2), p.118-126

2020

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Alimentary pharmacology & therapeutics, 2019-11, Vol.50 (10), p.1127-1136

2019

Link zum Volltext

Verfügbarkeit prüfen

Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study

European journal of internal medicine, 2024-05, Vol.123, p.127-131

2024

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome

Critical care (London, England), 2013-10, Vol.17 (5), p.R247-R247

2013

Link zum Volltext

Verfügbarkeit prüfen

Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis

The American journal of gastroenterology, 2023-07, Vol.118 (7), p.1196-1203

2023

Link zum Volltext

Verfügbarkeit prüfen

Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study

European journal of internal medicine, 2024-04, Vol.122, p.78-85

2024

Link zum Volltext

Verfügbarkeit prüfen

Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed

BMJ case reports, 2020-12, Vol.13 (12), p.e238400

2020

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

Journal of autoimmunity, 2022-10, Vol.132, p.102906-102906, Article 102906

2022

Link zum Volltext

Verfügbarkeit prüfen

COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis

European journal of internal medicine, 2017-03, Vol.38, p.83-88

2017

Link zum Volltext

Verfügbarkeit prüfen

Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe

European journal of gastroenterology & hepatology, 2023-01, Vol.35 (1), p.112

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease

Autoimmunity (Chur, Switzerland), 2013-11, Vol.46 (7), p.471-479

2013

Link zum Volltext

Verfügbarkeit prüfen

Primary biliary cirrhosis and Henoch–Schonlein purpura: report of two cases and review of the literature

Liver international, 2007-03, Vol.27 (2), p.280-283

2007

Link zum Volltext

Verfügbarkeit prüfen

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus

BMJ case reports, 2019-03, Vol.12 (3), p.e228524

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis

BMJ case reports, 2017-09, Vol.2017, p.bcr-2017-220824

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score?

Digestive and liver disease, 2010-11, Vol.42 (11), p.807-812

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

World journal of gastroenterology : WJG, 2005-01, Vol.11 (4), p.482

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases

Decreased serum DNase1-activity in patients with autoimmune liver diseases

NAFLD and autoimmune hepatitis: Do not judge a book by its cover

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome

Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis

Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one‐year non‐responders and predicts survival

Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group

Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis

Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe

Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease

Primary biliary cirrhosis and Henoch–Schonlein purpura: report of two cases and review of the literature

Glycogenic hepatopathy as a cause of severe deranged liver enzymes in a young patient with type 1 diabetes mellitus

Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis

Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: A new or a complementary diagnostic score?

Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot study

Aktive Filter

Suchergebnisse filtern